Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds outbreak of Cipro web sites followed anthrax outbreak

13.09.2002


Web sites selling the prescription-only medication ciprofloxacin (also known by its brand name Cipro®) sprang up quickly following an anthrax outbreak in October 2001, according to a new study by researchers from the Case Western Reserve University (CWRU) School of Medicine. The study, published today in the American Journal of Medicine, also found that these Web sites provided poor quality information, had inadequate consumer safeguards, and charged high prices.



On Oct. 4, 2001, the U.S. Centers for Disease Control and Prevention reported the first case of an anthrax outbreak by mail. Immediately following the anthrax outbreak, numerous Web sites began selling ciprofloxacin, then the only U.S. Food and Drug Administration (FDA)-approved drug to treat anthrax exposure. The outbreak provided the research team with a unique opportunity to illustrate the general difficulties regulators have had with these so-called "Internet pharmacies" that sell prescription drugs directly to the general public.

The researchers compiled information on 59 Web sites selling ciprofloxacin without a prescription between Oct. 28 and Oct. 31, 2001. Twenty-three sites (39 percent) had been created during the two weeks following the Oct. 4, 2001 announcement of the anthrax outbreak. Within a month, 29 sites (49 percent) had discontinued ciprofloxacin sales.


"The host of Web sites we identified sprouted up within two weeks of the anthrax outbreak – one outbreak immediately following the other," said Alexander Tsai, a fourth-year CWRU medical student in the Dual Degree Program in Medicine and Health Services Research. "These online sales of prescription-only medications clearly do not involve any meaningful medical assessment, which is necessary when prescribing a potentially dangerous antibiotic like ciprofloxacin."

Most state medical practice acts stipulate that a physician must examine a patient before prescribing a medication. However, none of the Web sites in the CWRU study required the customer to mail or fax in a physician’s prescription. Forty-nine sites (81 percent) simply asked the customer to fill out an online questionnaire with minimal questions about the customer’s medical history and symptoms. The other eleven sites (19 percent) did not even require customers to fill out a medical questionnaire for purchase.

Tsai conducted this study with the help of Dr. Peter Lurie, deputy director of the Washington D.C.-based Public Citizen’s Health Research Group, and Dr. Ashwini Seghal, a nephrologist at MetroHealth Medical Center and an associate professor of medicine at CWRU. The researchers also had concerns about the quality of these Web sites. Seventeen of the 59 sites (29 percent) displayed no information about potential adverse effects, and 16 sites (27 percent) did not mention the danger of life-threatening allergic reactions if patients with a history of hypersensitivity to quinolone antibiotics (such as ciprofloxacin) use the drug. On eight sites (14 percent), the researchers documented false or misleading claims.

During the study period, state authorities brought enforcement actions against three of the Web sites in the CWRU study. Also in response to the Internet explosion of Web sites selling ciprofloxacin, the FDA ordered all private ciprofloxacin shipments arriving from overseas to be stopped at the border. Eleven of the 59 sites (19 percent) were based in foreign countries, while the rest were registered to U.S. addresses.

"The sale of prescription drugs on the Internet is both a federal and state issue, but neither has the resources or adequate legal authority to act quickly enough," said Lurie. "The problem is that feds have largely deferred to the states – but the states have not filled the regulatory vacuum."

Tsai said he was inspired to undertake the research project after studying the work of other researcher-activists. Sehgal teaches an "Activism and Medicine" elective class for CWRU medical students. More information about this class can be found at http://home.cwru.edu/activism

George Stamatis | EurekAlert!
Further information:
http://www.cwru.edu/
http://home.cwru.edu/activism

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>